MicroRNA-379-5p plays a tumor-suppressive role in human bladder cancer growth and metastasis by directly targeting MDM2

Zhang, 2014, Genetic variations rs11892031 and rs401681 are associated with bladder cancer risk in a Chinese population, Int J Mol Sci, 15, 19330, 10.3390/ijms151119330

Siegel, 2015, Cancer statistics, 2015, CA Cancer J Clin, 65, 5, 10.3322/caac.21254

Knowles, 2008, Molecular pathogenesis of bladder cancer, Int J Clin Oncol, 13, 287, 10.1007/s10147-008-0812-0

Scélo, 2007, The epidemiology of bladder and kidney cancer, Nat Clin Pract Urol, 4, 205, 10.1038/ncpuro0760

Wu, 2014, microRNA-99a inhibiting cell proliferation, migration and invasion by targeting fibroblast growth factor receptor 3 in bladder cancer, Oncol Lett, 7, 1219, 10.3892/ol.2014.1875

Kim, 2008, Molecular biomarkers in urothelial bladder cancer, Cancer Sci, 99, 646, 10.1111/j.1349-7006.2008.00735.x

Ambros, 2003, MicroRNA pathways in flies and worms: Growth, death, fat, stress, and timing, Cell, 113, 673, 10.1016/S0092-8674(03)00428-8

Bartel, 2009, MicroRNAs: Target recognition and regulatory functions, Cell, 136, 215, 10.1016/j.cell.2009.01.002

Bartel, 2004, MicroRNAs: Genomics, biogenesis, mechanism, and function, Cell, 116, 281, 10.1016/S0092-8674(04)00045-5

Wu, 2007, MicroRNA and cancer: Current status and prospective, Int J Cancer, 120, 953, 10.1002/ijc.22454

Nelson, 2008, MicroRNAs and cancer: Past, present, and potential future, Mol Cancer Ther, 7, 3655, 10.1158/1535-7163.MCT-08-0586

Garzon, 2006, MicroRNA expression and function in cancer, Trends Mol Med, 12, 580, 10.1016/j.molmed.2006.10.006

Alvarez-Garcia, 2005, MicroRNA functions in animal development and human disease, Development, 132, 4653, 10.1242/dev.02073

Tana, 2017, microRNA profiling in atherosclerosis, diabetes and migraine, Ann Med, 49, 93, 10.1080/07853890.2016.1226515

Piletič, 2016, MicroRNA epigenetic signatures in human disease, Arch Toxicol, 90, 2405, 10.1007/s00204-016-1815-7

Shang, 2016, MicroRNA-383 is a tumor suppressor and potential prognostic biomarker in human non-small cell lung caner, Biomed Pharmacother, 83, 1175, 10.1016/j.biopha.2016.08.006

Calin, 2006, MicroRNA signatures in human cancers, Nat Rev Cancer, 6, 857, 10.1038/nrc1997

Khan, 2013, miR-379 regulates cyclin B1 expression and is decreased in breast cancer, PLoS One, 8, e68753, 10.1371/journal.pone.0068753

Chen, 2016, MicroRNA-379-5p inhibits tumor invasion and metastasis by targeting FAK/AKT signaling in hepatocellular carcinoma, Cancer Lett, 375, 73, 10.1016/j.canlet.2016.02.043

Chen, 2016, Effects of microRNA-379-5p on proliferation, migration and invasion of hepatocellular carcinoma cell line, Zhonghua Yi Xue Za Zhi, 96, 1450

Livak, 2001, Analysis of relative gene expression data using real-time quantitative PCR and the 2ΔΔCT method, Methods, 25, 402, 10.1006/meth.2001.1262

Zhong, 2012, MicroRNA-421 functions as an oncogenic miRNA in biliary tract cancer through down-regulating farnesoid X receptor expression, Gene, 493, 44, 10.1016/j.gene.2011.11.028

Wu, 2016, MicroRNA-335 is downregulated in bladder cancer and inhibits cell growth, migration and invasion via targeting ROCK1, Mol Med Rep, 13, 4379, 10.3892/mmr.2016.5055

Wang, 2016, MiR-124 inhibits cell proliferation, migration and invasion by directly targeting SOX9 in lung adenocarcinoma, Oncol Rep, 35, 3115, 10.3892/or.2016.4648

Baker, 2010, RNA interference: MicroRNAs as biomarkers, Nature, 464, 1227, 10.1038/4641227a

Gururajan, 2014, miR-154* and miR-379 in the DLK1-DIO3 microRNA mega-cluster regulate epithelial to mesenchymal transition and bone metastasis of prostate cancer, Clin Cancer Res, 20, 6559, 10.1158/1078-0432.CCR-14-1784

Osada, 2007, MicroRNAs in biological processes and carcinogenesis, Carcinogenesis, 28, 2, 10.1093/carcin/bgl185

Pichiorri, 2016, Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development, Cancer Cell, 18, 349, 10.1016/j.ccell.2016.07.007

Marchetti, 1995, mdm2 gene alterations and mdm2 protein expression in breast carcinomas, J Pathol, 175, 31, 10.1002/path.1711750106

Marchetti, 1995, mdm2 gene amplification and overexpression in non-small cell lung carcinomas with accumulation of the p53 protein in the absence of p53 gene mutations, Diagn Mol Pathol, 4, 93, 10.1097/00019606-199506000-00004

Zhang, 2014, MicroRNA-339-5p inhibits colorectal tumorigenesis through regulation of the MDM2/p53 signaling, Oncotarget, 5, 9106, 10.18632/oncotarget.2379

Riou, 1995, The p53 and mdm-2 genes in human testicular germ-cell tumors, Mol Carcinog, 12, 124, 10.1002/mc.2940120303

Lianes, 1994, Altered patterns of MDM2 and TP53 expression in human bladder cancer, J Natl Cancer Inst, 86, 1325, 10.1093/jnci/86.17.1325

Tuna, 2003, Expression of p53 and mdm2 and their significance in recurrence of superficial bladder cancer, Pathol Res Pract, 199, 323, 10.1078/0344-0338-00424

Schmitz-Dräger, 1997, p53 and MDM2 in the development and progression of bladder cancer, Eur Urol, 32, 487, 10.1159/000480813

Shiina, 1999, Clinical significance of mdm2 and p53 expression in bladder cancer. A comparison with cell proliferation and apoptosis, Oncology, 56, 239, 10.1159/000011971